Volitionrx VNRX
NYSE VNRX
$0.45 -0.04 (-7.74%)
At close: Aug 20, 2026 · 11:16 AM UTC

Volitionrx (VNRX) Cost of Revenue (2019)

Volitionrx's (VNRX) quarterly Cost of Revenue came in at $892.0 in Q3 2019.

Volitionrx (VNRX) Cost of Revenue (2019) Analysis & Trends

Volitionrx (VNRX) has 1 years of Cost of Revenue data on file, last reported at $892.0 in Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn 5.33 Bn
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn 2.09 Bn
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn 3.40 Bn
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn 1.59 Bn
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn 392.40 Mn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn 478.40 Mn
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn 2.25 Bn
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn 2.57 Bn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn 808.60 Mn
10 Volitionrx 1.21 Mn -1.58 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2019 892.00
Sep 30, 2019 892.00